教員業績データベース |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Impact of first-line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma. |
掲載誌名 | 正式名:Journal of gastroenterology and hepatology ISSNコード:14401746/08159319 |
掲載区分 | 国外 |
巻・号・頁 | 38(8),pp.1389-1397 |
著者・共著者 | Hatanaka Takeshi, Kakizaki Satoru, Hiraoka Atsushi, Tada Toshifumi, Hirooka Masashi, Kariyama Kazuya, Tani Joji, Atsukawa Masanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Kunihiro, Ishikawa Toru, Tajiri Kazuto, Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara, Nishimura Takashi, Shimada Noritomo, Kawata Kazuhito, Kosaka Hisashi, Naganuma Atsushi, Yata Yutaka, Tanaka Takaaki, Ohama Hideko, Tada Fujimasa, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi, Nagano Takuya, Itokawa Norio, Okubo Tomomi, Arai Taeang, Imai Michitaka, Koizumi Yohei, Nakamura Shinichiro, Kaibori Masaki, Iijima Hiroko, Hiasa Yoichi, Kumada Takashi Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan) |
発行年月 | 2023/08 |